Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-08-18

FDA Approved: INVOKAMET XR — Supplemental Application (Janssen Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for INVOKAMET XR (canagliflozin and metformin hydrochloride) from Janssen Pharmaceuticals to modify/expand the product l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • INVOKAMET XR (CANAGLIFLOZIN AND METFORMIN HYDROCHLORIDE)

Snippet

SUPPL AP for INVOKAMET XR (CANAGLIFLOZIN AND METFORMIN HYDROCHLORIDE)